an experimental experience

Loading
Loading...

Johns Hopkins Study Supports Potential for Injectable 'Chemical Vaccine' For Malaria Using Atovaquone | Johns Hopkins | Bloomberg School of Public Health - Johns Hopkins Bloomberg School of Public Health

10/20/23 at 1:00pm

Organization

Jhu.edu

52 words

Comments

Researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown that resistance may not be the challenge scientists thought it was.

Health Johns Hopkins Study Supports Potential for Injectable 'Chemical Vaccine Johns Hopkins University Johns Hopkins Bloomberg School of Public Health Researchers Johns Hopkins Bloomberg challenge scientists malaria preventive

You are the first to view

https://publichealth.jhu.edu/2023/johns-hopkins-study-supports-potential-for-injectable-chemical-vaccine-for-malaria-using-atovaquone

Create an account or login to join the discussion